Emmanuel J Favaloro/LinkedIn
Jun 19, 2026, 22:46
Emmanuel J. Favaloro: Machine Learning Driving Innovation in Thrombosis and Hemostasis
Emmanuel J. Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis at Westmead Hospital, Editor in Chief of Seminars in Thrombosis and Hemostasis, shared a post on LinkedIn about a recent article Michael Nagler et al, published in Seminars in Thrombosis and Hemostasis, adding:
“Making Machine Learning Clinically Useful in Thrombosis and Hemostasis.
Just uploaded to Seminars in cand Hemostasis.
Free to download.
Enjoy!”
Title: Making Machine Learning Clinically Useful in Thromb
Authors: Michael Nagler, Henning Nilius, Janna Hastings, Christos Nakas
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering